Literature DB >> 2907377

Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue.

G P Reynolds1, C E Warner.   

Abstract

Neurotransmitter amino acids have been measured in several brain regions taken postmortem from 5 adults cases of Down's syndrome and 6 age-matched control subjects. A significant deficit of glutamate was found in the hippocampus in Down's syndrome, and gamma-aminobutyric acid was reduced in the hippocampus and temporal cortex in those patients with neocortical neurofibrillary tangles. These results are consistent with losses of cortical neurones containing these neurotransmitters, and resemble the deficits exhibited by the more severely affected cases of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907377     DOI: 10.1016/0304-3940(88)90299-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn.

Authors:  Samuel Hernández-González; Raúl Ballestín; Rosa López-Hidalgo; Javier Gilabert-Juan; José Miguel Blasco-Ibáñez; Carlos Crespo; Juan Nácher; Emilio Varea
Journal:  Neurochem Res       Date:  2014-11-16       Impact factor: 3.996

2.  Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable o-phthalaldehyde-sulphite derivatives.

Authors:  S J Pearson; C Czudek; K Mercer; G P Reynolds
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome.

Authors:  Gurjinder Kaur; Ajay Sharma; Wenjin Xu; Scott Gerum; Melissa J Alldred; Shivakumar Subbanna; Balapal S Basavarajappa; Monika Pawlik; Masuo Ohno; Stephen D Ginsberg; Donald A Wilson; David N Guilfoyle; Efrat Levy
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

Review 4.  Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease.

Authors:  Robert A Rissman; William C Mobley
Journal:  J Neurochem       Date:  2011-03-28       Impact factor: 5.372

5.  The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Authors:  Md Mahiuddin Ahmed; Athena Ching-Jung Wang; Mihret Elos; Heidi J Chial; Stefan Sillau; D Adriana Solano; Christina Coughlan; Leila Aghili; Paige Anton; Neil Markham; Vanesa Adame; Katheleen J Gardiner; Timothy D Boyd; Huntington Potter
Journal:  Neurobiol Dis       Date:  2022-03-18       Impact factor: 7.046

6.  Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.

Authors:  Lisi Flores-Aguilar; M Florencia Iulita; Olivia Kovecses; Maria D Torres; Sarah M Levi; Yian Zhang; Manor Askenazi; Thomas Wisniewski; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

7.  Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS).

Authors:  Giles My Tan; Felix Beacher; Eileen Daly; Jamie Horder; Verinder Prasher; Maria-Luisa Hanney; Robin Morris; Simon Lovestone; Kieran C Murphy; Andrew Simmons; Declan Gm Murphy
Journal:  J Neurodev Disord       Date:  2014-11-27       Impact factor: 4.025

Review 8.  Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.

Authors:  Gabriele Deidda; Ignacio F Bozarth; Laura Cancedda
Journal:  Front Cell Neurosci       Date:  2014-05-22       Impact factor: 5.505

Review 9.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

10.  Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome.

Authors:  Xin Wang; Yingjun Zhao; Xiaofei Zhang; Hedieh Badie; Ying Zhou; Yangling Mu; Li Shen Loo; Lei Cai; Robert C Thompson; Bo Yang; Yaomin Chen; Peter F Johnson; Chengbiao Wu; Guojun Bu; William C Mobley; Dongxian Zhang; Fred H Gage; Barbara Ranscht; Yun-wu Zhang; Stuart A Lipton; Wanjin Hong; Huaxi Xu
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.